Sponsor content
217 result(s) found, displaying 11 to 20
-
Cancellation by sponsorRequested by CSL Behring (Australia) Pty Ltd
-
Cancellation by sponsorRequested by CSL Behring (Australia) Pty Ltd
-
Cancellation by sponsorRequested by CSL Behring (Australia) Pty Ltd
-
Cancellation by sponsorRequested by CSL Behring (Australia) Pty Ltd
-
Cancellation by sponsorRequested by CSL Behring (Australia) Pty Ltd
-
Cancellation by sponsorRequested by CSL Behring (Australia) Pty Ltd
-
Australian public assessment report (AusPar)Andembry was approved for the prevention of recurrent hereditary angioedema (HAE) attacks in patients aged 12 years and older with C1-INH HAE (C1-esterase inhibitor deficiency or dysfunction).
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CSL US AlbuRx 5 human albumin 50 g/L (5% w/v) solution for intravenous infusion vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CSL Hong Kong Albumex 5 NexGen Human Albumin 50 g/L Solution for Intravenous Infusion.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CSL United States of America Privigen normal immunoglobulin (human) (100g/L, 10%) solution for intravenous solution.